期刊文献+

干扰小RNA下调瘦素受体抑制人骨关节炎软骨细胞白细胞介素-1β和一氧化氮的信使RNA表达 被引量:3

Down-regulated Leptin Receptor by Small Interfering RNA Inhibits the Messenger RNA Expressions of Interleukin-1β and Nitric Oxide of Human Osteoarthritis Chondrocytes
原文传递
导出
摘要 目的观察干扰小RNA(si RNA)下调瘦素受体对人骨关节炎软骨细胞白细胞介素(IL)-1β和一氧化氮(NO)表达的抑制作用,为临床基础研究提供参考依据。方法取全膝置换术患者残存的无菌膝关节软骨进行分离培养人关节软骨细胞,取第3代软骨细胞对瘦素受体的Ob-Rb的分别用携带si RNA的脂质体(实验组)和空白脂质体(对照组)进行转染,转染成功后24、48、72 h采用荧光定量聚合酶链反应测前炎性因子基因IL-1β和NO的信使RNA表达量。结果转染成功后24、48及72 h,实验组IL-1β的表达逐渐略有上升,NO的m RNA表达逐渐下降,但均明显低于对照组(P<0.05),且随时间推移差值逐渐变大。结论 si RNA技术下调瘦素受体可明显抑制人骨关节炎软骨细胞IL-1β和NO的m RNA的表达水平。 Objective To study the effect of down-regulated leptin receptor by small interfering RNA (siRNA) in inhibiting the messenger RNA (mRNA) expressions of interleukin (IL)-1β and nitric oxide (NO) of human osteoarthritis chondrocytes, in order to provide reference for basic clinical research. Methods Cartilage was harvested under sterile conditions from osteoarthritis knee joints in patients undergoing total knee arthroplasty. Human articular chondrocytes were isolated and the cells were cultured in vitro. The cells in the 3rd passage were transferred by siRNA Ob-Rb (experimental group) and blank Ob-Rb (control group), respectively. Then mRNA expressions of IL-1β and NO were tested by quantitative polyrnerase chain reaction at hour 24, 48 and 72 after successful transfection. Results The mRNA expressions of IL-1β increased slightly and that of NO declined slightly at hour 24, 48 and 72 after transfection in the treatment group, but they all were significantly lower than those in the control group (P 〈 0.05), and the differences became much larger as time went on. Conclusion Leptin receptor under siRNA technology can significantly inhibit the mRNA expressions of IL-1β and NO in human osteoarthritis chondrocytes,
出处 《华西医学》 CAS 2016年第5期854-858,共5页 West China Medical Journal
基金 国家青年自然基金项目(81101388)~~
关键词 骨关节炎 人软骨细胞 干扰小RNA 白细胞介素-1Β 一氧化氮 Osteoarthritis Human chondrocytes Small interfering RNA Interleukin-1β Nitric oxide
  • 相关文献

参考文献20

  • 1Creamer P, Hochberg MC. Osteoarthritis[J]. Lancet, 1997, 350(9076): 503-508.
  • 2Isogai N, Kusuhara H, Ikada Y, et al. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures[J]. Tissue Eng, 2006, 12(4): 691-703.
  • 3Alsalameh S, Amin R, Gemba T, et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage[J]. Arthritis Rheum, 2004, 50(5): 1522-1532.
  • 4Felson DT, Kim YJ. The futility of current approaches to chondroprotection[J]. Arthritis Rheum, 2007, 56(5): 1378-1383.
  • 5Samuels J, Krasnokutsky S, Abramson SB. Osteoarthritis: a tale of three tissues[J]. Bull NYU Hosp Jt Dis, 2008, 66(3): 244-250.
  • 6Adamczak M, Wiecek A. The adipose tissue as an endocrine organ[J], Semin Nephrol, 2013, 33(1): 2-13.
  • 7Gabay O, Berenbaum F. Adipokines in arthritis: new Kids on the block[J]. Curr Rheumatol Rev, 2009, 5(4): 226-232.
  • 8Otero M, Lago R, Lago F, et al. Signalling pathway involved in nitric oxide synthase type ]1 activation in chondrocytes: synergistic effect of leptin with interleukin-l[J]. Arthritis Res Ther, 2005, 7(3): R581-R591.
  • 9Conde J, Scotece M, G6mez R, et al. Adipokinesand osteoarthritis: novel molecules involved in the pathogenesis and progression of disease[J]. Arthritis, 2011(2011): 203901.
  • 10Yang WH, Liu SC, Tsai CH, et al. Leptin induces IL-6 expression through OBR1 receptor signaling pathway in human synovial fibroblasts[J]. PLoS One, 2013, 8(9): e75551.

同被引文献33

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部